Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular DeathPaul Brady, Paulus Kirchhof, Muhammad Jawad‐Ul‐Qamar et al.|Journal of the American Heart Association|2022Cited by 45
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditionsWinnie Chua, Larissa Fabritz, Victor Roth Cardoso et al.|Scientific Reports|2023Cited by 28
Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation studyWinnie Chua, Larissa Fabritz, Jonathan P. Law et al.|PLoS Medicine|2021Cited by 18